Advertisement
Screener

Neogen Corporation (NEOG) Other Comprehensive Income (Loss), Net of Tax

2.2 / 5 stars · 53/120 Roast Me

Neogen Corporation Other Comprehensive Income (Loss), Net of Tax

Neogen Corporation (NEOG) reported Other Comprehensive Income (Loss), Net of Tax of $15.30 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30

  • Neogen Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-05-31 was -$1.10M, a 105.85% decline year-over-year.
  • Neogen Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-02-28 was $13.10M.
  • Neogen Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-11-30 was -$2.10M.
  • Neogen Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-08-31 was $5.40M.
  • Neogen Corporation other comprehensive income (loss), net of tax for fiscal 2026 was $15.30M, a 1290.91% increase from fiscal 2025.
  • Neogen Corporation other comprehensive income (loss), net of tax for fiscal 2025 was $1.10M, a 65.63% decline from fiscal 2024.
  • Neogen Corporation other comprehensive income (loss), net of tax for fiscal 2024 was $3.20M.
  • Neogen Corporation other comprehensive income (loss), net of tax for fiscal 2023 was -$5.48M.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 3 month as first filedOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 9 month as first filedOther Comprehensive Income (Loss), Net of Tax 12 monthOther Comprehensive Income (Loss), Net of Tax 12 month as first filed
2026-05-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$12.00M
derived: sum of 2 quarters · filed 2026-07-30
$9.90M
derived: sum of 3 quarters · filed 2026-07-30
$15.30M
10-K · filed 2026-07-30
2026-02-28$13.10M
10-Q · filed 2026-04-09
$11.00M
derived: sum of 2 quarters · filed 2026-04-09
$16.40M
10-Q · filed 2026-04-09
$35.20M
derived: sum of 4 quarters · filed 2026-07-30
2025-11-30-$2.10M
10-Q · filed 2026-04-09
-$2.12M
10-Q · filed 2026-01-08
$3.29M
10-Q · filed 2026-01-08
$22.10M
derived: sum of 3 quarters · filed 2026-07-30
$19.10M
derived: sum of 4 quarters · filed 2026-07-30
2025-08-31$5.40M
10-Q · filed 2026-04-09
$5.41M
10-Q · filed 2025-10-09
$24.20M
derived: sum of 2 quarters · filed 2026-07-30
$21.20M
derived: sum of 3 quarters · filed 2026-07-30
$7.90M
derived: sum of 4 quarters · filed 2026-07-30
2025-05-31$18.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$15.80M
derived: sum of 2 quarters · filed 2026-07-30
$2.50M
derived: sum of 3 quarters · filed 2026-07-30
$1.10M
10-K · filed 2026-07-30
$1.12M
10-K · filed 2025-07-30
2025-02-28-$3.00M
10-Q · filed 2026-04-09
-$2.94M
10-Q · filed 2025-04-09
-$16.30M
derived: sum of 2 quarters · filed 2026-04-09
-$17.70M
10-Q · filed 2026-04-09
-$17.67M
10-Q · filed 2025-04-09
-$18.28M
derived: sum of 4 quarters · filed 2026-07-30
2024-11-30-$13.30M
10-Q · filed 2026-04-09
-$13.32M
10-Q · filed 2025-01-15
-$14.72M
10-Q · filed 2026-01-08
-$15.28M
derived: sum of 3 quarters · filed 2026-07-30
-$19.62M
derived: sum of 4 quarters · filed 2026-07-30
2024-08-31-$1.40M
10-Q · filed 2026-04-09
-$1.98M
derived: sum of 2 quarters · filed 2026-07-30
-$6.32M
derived: sum of 3 quarters · filed 2026-07-30
-$4.96M
derived: sum of 4 quarters · filed 2026-07-30
2024-05-31-$578.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
-$4.92M
derived: sum of 2 quarters · filed 2026-07-30
-$3.56M
derived: sum of 3 quarters · filed 2026-07-30
$3.20M
10-K · filed 2026-07-30
$3.23M
10-K · filed 2024-07-30
2024-02-29-$4.34M
10-Q · filed 2025-04-09
-$2.98M
derived: sum of 2 quarters · filed 2025-04-09
$3.78M
10-Q · filed 2025-04-09
$3.75M
derived: sum of 4 quarters · filed 2025-07-30
2023-11-30$1.37M
10-Q · filed 2025-04-09
$8.12M
10-Q · filed 2025-01-15
$8.09M
derived: sum of 3 quarters · filed 2025-07-30
$15.37M
derived: sum of 4 quarters · filed 2025-07-30
2023-08-31$6.75M
10-Q · filed 2025-04-09
$6.73M
derived: sum of 2 quarters · filed 2025-07-30
$14.00M
derived: sum of 3 quarters · filed 2025-07-30
$12.83M
derived: sum of 4 quarters · filed 2025-07-30
2023-05-31-$29.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30
$7.25M
derived: sum of 2 quarters · filed 2025-07-30
$6.08M
derived: sum of 3 quarters · filed 2025-07-30
-$5.48M
10-K · filed 2025-07-30
2023-02-28$7.28M
10-Q · filed 2024-04-09
$6.10M
derived: sum of 2 quarters · filed 2024-04-09
-$5.45M
10-Q · filed 2024-04-09
2022-11-30-$1.17M
10-Q · filed 2024-04-09
-$12.73M
10-Q · filed 2024-01-09
2022-08-31-$11.56M
10-Q · filed 2024-04-09
2022-05-31-$16.39M
10-K · filed 2024-07-30
2022-02-28$1.80M
10-Q · filed 2023-04-04
-$6.24M
derived: sum of 2 quarters · filed 2023-04-04
-$11.06M
derived: sum of 3 quarters · filed 2023-04-04
2021-11-30-$8.03M
10-Q · filed 2023-04-04
-$12.86M
derived: sum of 2 quarters · filed 2023-04-04
2021-08-31-$4.83M
10-Q · filed 2023-04-04
2021-05-31$8.33M
10-K · filed 2023-08-15
2021-02-28$245.00K
10-Q · filed 2022-04-01
$866.00K
derived: sum of 2 quarters · filed 2022-04-01
$4.87M
derived: sum of 3 quarters · filed 2022-04-01
2020-11-30$621.00K
10-Q · filed 2022-04-01
$4.62M
derived: sum of 2 quarters · filed 2022-04-01
2020-08-31$4.00M
10-Q · filed 2022-04-01
2020-05-31-$5.48M
10-K · filed 2023-08-15
-$8.07M
10-K · filed 2020-07-30
2020-02-29-$1.59M
10-Q · filed 2021-03-31
$629.00K
derived: sum of 2 quarters · filed 2021-03-31
-$1.87M
derived: sum of 3 quarters · filed 2021-03-31
2019-11-30$2.22M
10-Q · filed 2021-03-31
-$278.00K
derived: sum of 2 quarters · filed 2021-03-31
2019-08-31-$2.50M
10-Q · filed 2021-03-31
2019-05-31-$1.89M
10-K · filed 2021-07-30
2019-02-28$3.10M
10-Q · filed 2020-04-03
$3.40M
derived: sum of 2 quarters · filed 2020-04-03
$617.00K
derived: sum of 3 quarters · filed 2020-04-03
-$3.83M
derived: sum of 4 quarters · filed 2020-07-30
2018-11-30$290.00K
10-Q · filed 2020-04-03
-$2.49M
10-Q · filed 2018-12-28
-$6.93M
derived: sum of 3 quarters · filed 2020-07-30
-$5.77M
derived: sum of 4 quarters · filed 2020-07-30
2018-08-31-$2.78M
10-Q · filed 2020-04-03
-$7.22M
derived: sum of 2 quarters · filed 2020-07-30
-$6.06M
derived: sum of 3 quarters · filed 2020-07-30
-$5.52M
derived: sum of 4 quarters · filed 2020-07-30
2018-05-31-$4.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30
-$3.28M
derived: sum of 2 quarters · filed 2020-07-30
-$2.75M
derived: sum of 3 quarters · filed 2020-07-30
-$2.54M
10-K · filed 2020-07-30
2018-02-28$1.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29
$1.70M
derived: sum of 2 quarters · filed 2018-03-29
$1.90M
10-Q · filed 2018-03-29
$2.39M
derived: sum of 4 quarters · filed 2019-07-30
2017-11-30$534.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$737.00K
10-Q · filed 2018-01-05
$1.22M
derived: sum of 3 quarters · filed 2019-07-30
$1.66M
derived: sum of 4 quarters · filed 2019-07-30
2017-08-31$203.00K
10-Q · filed 2017-09-29
$689.00K
derived: sum of 2 quarters · filed 2019-07-30
$1.13M
derived: sum of 3 quarters · filed 2019-07-30
-$476.00K
derived: sum of 4 quarters · filed 2019-07-30
2017-05-31$486.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30
$927.00K
derived: sum of 2 quarters · filed 2019-07-30
-$679.00K
derived: sum of 3 quarters · filed 2019-07-30
-$3.26M
10-K · filed 2019-07-30
2017-02-28$441.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31
-$1.17M
derived: sum of 2 quarters · filed 2017-03-31
-$3.74M
10-Q · filed 2017-03-31
-$2.00M
derived: sum of 4 quarters · filed 2018-07-27
2016-11-30-$1.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29
-$4.18M
10-Q · filed 2016-12-29
-$2.44M
derived: sum of 3 quarters · filed 2018-07-27
-$4.68M
derived: sum of 4 quarters · filed 2018-07-27
2016-08-31-$2.58M
10-Q · filed 2016-09-30
-$830.00K
derived: sum of 2 quarters · filed 2018-07-27
-$3.08M
derived: sum of 3 quarters · filed 2018-07-27
-$3.37M
derived: sum of 4 quarters · filed 2018-07-27
2016-05-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27
-$497.00K
derived: sum of 2 quarters · filed 2018-07-27
-$791.00K
derived: sum of 3 quarters · filed 2018-07-27
-$1.50M
10-K · filed 2018-07-27
2016-02-29-$2.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31
-$2.54M
derived: sum of 2 quarters · filed 2016-03-31
-$3.25M
10-Q · filed 2016-03-31
-$3.56M
derived: sum of 4 quarters · filed 2017-07-28
2015-11-30-$294.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08
-$1.01M
10-Q · filed 2016-01-08
-$1.31M
derived: sum of 3 quarters · filed 2017-07-28
-$1.96M
derived: sum of 4 quarters · filed 2017-07-28
2015-08-31-$713.00K
10-Q · filed 2015-09-30
-$1.02M
derived: sum of 2 quarters · filed 2017-07-28
-$1.67M
derived: sum of 3 quarters · filed 2017-07-28
-$3.31M
derived: sum of 4 quarters · filed 2017-07-28
2015-05-31-$308.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
-$956.00K
derived: sum of 2 quarters · filed 2017-07-28
-$2.59M
derived: sum of 3 quarters · filed 2017-07-28
-$2.81M
10-K · filed 2017-07-28
2015-02-28-$648.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01
-$2.29M
derived: sum of 2 quarters · filed 2015-04-01
-$2.50M
10-Q · filed 2015-04-01
2014-11-30-$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30
-$1.86M
10-Q · filed 2014-12-30
2014-08-31-$219.00K
10-Q · filed 2014-09-30
2014-05-31$1.74M
10-K · filed 2016-07-29
2013-05-31-$145.00K
10-K · filed 2015-07-30
2012-05-31-$833.00K
10-K · filed 2014-07-30
2011-05-31$1.28M
10-K · filed 2013-07-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93